Focus Partners Advisor Solutions, LLC
Position in IRWD — Ironwood Pharmaceuticals Inc
CIK 1868872
SAINT LOUIS, MO
Position in IRWD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$141,557
-$76,315 QoQ
Shares Held
33,624
-45.8% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#121
of 211 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Focus Partners Advisor Solutions, LLC holds $5,018,095 across 7 Drug Manufacturers - Specialty & Generic names. IRWD ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
11,434 | $1,927,086 | |
| 2 | VTRS |
Viatris Inc
|
88,753 | $1,409,397 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,467 | $794,864 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,587 | $324,807 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
14,302 | $229,261 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
13,190 | $191,123 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
This page
|
33,624 | $141,557 |
All Filings in IRWD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $141,557 | 33,624 | Shares | Other | 2026-08-06 | |
| 2026-03-31 | $217,872 | 62,072 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $200,909 | 59,617 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $68,506 | 52,295 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $28,614 | 39,743 | Shares | Other | 2025-07-31 | |
| 2025-03-31 | $15,190 | 10,334 | Shares | Other | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||